18don MSN
Pfizer’s new weight-loss shot: Can one injection a month change obesity treatment as we know it?
With promising mid-stage trial results, berobenatide aims to make obesity treatment more convenient without compromising effectiveness.
The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this limitation through advanced molecular engineering techniques.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results